Bavarian Nordic secures EU approval for first chikungunya vaccine

Bavarian Nordic, a Danish biotechnology company specializing in vaccine development, was on 28 February 2025 granted marketing authorization in the EU for their chikungunya vaccine, VIMKUNYA®. Chikungunya is a mosquito-borne …

Bavarian Nordic secures EU approval for first chikungunya vaccine Read More

Novo Nordisk sues Singapore biotech firm over $1.3 billion acquisition dispute

Novo Nordisk, the Danish pharmaceutical giant, has filed a lawsuit against Singapore-based KBP Biosciences and its founder, Huang Zhenhua, alleging KBP Biosciences misrepresented the effectiveness of an experimental hypertension drug, …

Novo Nordisk sues Singapore biotech firm over $1.3 billion acquisition dispute Read More